165 related articles for article (PubMed ID: 9010298)
21. Different B-cell responses to human T-cell lymphotropic virus type I (HTLV-I) envelope synthetic peptides in HTLV-I-infected individuals.
Ida H; Kurata A; Eguchi K; Kawakami A; Migita K; Fukuda T; Nakamura T; Kusumoto Y; Berzofsky JA; Nagataki S
J Clin Immunol; 1991 May; 11(3):143-51. PubMed ID: 1890164
[TBL] [Abstract][Full Text] [Related]
22. A peptide-based human T cell leukemia virus type I vaccine containing T and B cell epitopes that induces high titers of neutralizing antibodies.
Baba E; Nakamura M; Ohkuma K; Kira J; Tanaka Y; Nakano S; Niho Y
J Immunol; 1995 Jan; 154(1):399-412. PubMed ID: 7527817
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of a HTLV-1 subunit vaccine in prevention of experimental STLV-I infection in Macaca nemestrina.
Dezzutti CS; Frazier DE; Lafrado LJ; Olsen RG
J Med Primatol; 1990; 19(3-4):305-16. PubMed ID: 2172541
[TBL] [Abstract][Full Text] [Related]
24. A Potential of an Anti-HTLV-I gp46 Neutralizing Monoclonal Antibody (LAT-27) for Passive Immunization against Both Horizontal and Mother-to-Child Vertical Infection with Human T Cell Leukemia Virus Type-I.
Fujii H; Shimizu M; Miyagi T; Kunihiro M; Tanaka R; Takahashi Y; Tanaka Y
Viruses; 2016 Feb; 8(2):. PubMed ID: 26848684
[TBL] [Abstract][Full Text] [Related]
25. Immunization with virion-derived glycoprotein 130 from HIV-2 or SIV protects macaques against challenge virus grown in human or simian cells or prepared ex vivo.
Stahl-Hennig C; Coulibaly C; Petry H; Voss G; Dittmer U; Bodemer W; Makoschey B; Jurkiewicz E; Lüke W; Hunsmann G
AIDS Res Hum Retroviruses; 1994; 10 Suppl 2():S27-32. PubMed ID: 7865316
[TBL] [Abstract][Full Text] [Related]
26. Highly attenuated HTLV type Ienv poxvirus vaccines induce protection against a cell-associated HTLV type I challenge in rabbits.
Franchini G; Tartaglia J; Markham P; Benson J; Fullen J; Wills M; Arp J; Dekaban G; Paoletti E; Gallo RC
AIDS Res Hum Retroviruses; 1995 Feb; 11(2):307-13. PubMed ID: 7742044
[TBL] [Abstract][Full Text] [Related]
27. Induction of neutralizing antibodies against HTLV-I envelope proteins after combined genetic and protein immunizations in mice.
Grange MP; Armand MA; Audoly G; Thollot D; Desgranges C
DNA Cell Biol; 1997 Dec; 16(12):1439-48. PubMed ID: 9428792
[TBL] [Abstract][Full Text] [Related]
28. Subunit vaccine protects Macaca nemestrina (pig-tailed macaque) against simian T-cell lymphotropic virus type I challenge.
Dezzutti CS; Frazier DE; Huff LY; Stromberg PC; Olsen RG
Cancer Res; 1990 Sep; 50(17 Suppl):5687S-5691S. PubMed ID: 2167165
[TBL] [Abstract][Full Text] [Related]
29. Multiple neutralizing B-cell epitopes of human T-cell leukemia virus type 1 (HTLV-1) identified by human monoclonal antibodies. A basis for the design of an HTLV-1 peptide vaccine.
Baba E; Nakamura M; Tanaka Y; Kuroki M; Itoyama Y; Nakano S; Niho Y
J Immunol; 1993 Jul; 151(2):1013-24. PubMed ID: 7687611
[TBL] [Abstract][Full Text] [Related]
30. Protective effects against simian immunodeficiency virus agm (SIVagm) infection in cynomolgus monkeys immunized with a recombinant vaccinia virus expressing the SIVagm envelope gene.
Ibuki K; Ido E; Funahashi S; Miura T; Hayami M; Shida H
Vaccine; 1999 Oct; 18(5-6):511-6. PubMed ID: 10519941
[TBL] [Abstract][Full Text] [Related]
31. Infection of rats with human T-cell leukemia virus type-I: susceptibility of inbred strains, antibody response and provirus location.
Ibrahim F; Fiette L; Gessain A; Buisson N; de-Thé G; Bomford R
Int J Cancer; 1994 Aug; 58(3):446-51. PubMed ID: 8050826
[TBL] [Abstract][Full Text] [Related]
32. Critical involvement of human T cell leukaemia virus type I virions in mediating the viral mitogenic effect.
Cassé H; Girerd Y; Gazzolo L; Duc Dodon M
J Gen Virol; 1994 Aug; 75 ( Pt 8)():1909-16. PubMed ID: 8046393
[TBL] [Abstract][Full Text] [Related]
33. A chimeric human T cell leukemia virus type I bearing a deltaR Moloney-murine leukemia virus envelope infects mice persistently and induces humoral and cellular immune responses.
Delebecque F; Combredet C; Gabet AS; Wattel E; Brahic M; Tangy F
J Infect Dis; 2005 Jan; 191(2):255-63. PubMed ID: 15609236
[TBL] [Abstract][Full Text] [Related]
34. Expression of HTLV-I envelope protein fused to hydrophobic amino-terminal peptide of baculovirus polyhedrin in insect cells and its application for serological assays.
Nyunoya H; Ogura T; Kikuchi M; Iwamoto H; Yamashita K; Maekawa M; Takebe Y; Miyamura K; Yamazaki S; Shimotohno K
AIDS Res Hum Retroviruses; 1990 Nov; 6(11):1311-21. PubMed ID: 2078412
[TBL] [Abstract][Full Text] [Related]
35. Human T-lymphotropic virus type 1 peptides in chimeric and multivalent constructs with promiscuous T-cell epitopes enhance immunogenicity and overcome genetic restriction.
Lairmore MD; DiGeorge AM; Conrad SF; Trevino AV; Lal RB; Kaumaya PT
J Virol; 1995 Oct; 69(10):6077-89. PubMed ID: 7545241
[TBL] [Abstract][Full Text] [Related]
36. Immunogenicity and safety of a recombinant vaccinia virus vaccine expressing the carcinoembryonic antigen gene in a nonhuman primate.
Kantor J; Irvine K; Abrams S; Snoy P; Olsen R; Greiner J; Kaufman H; Eggensperger D; Schlom J
Cancer Res; 1992 Dec; 52(24):6917-25. PubMed ID: 1458480
[TBL] [Abstract][Full Text] [Related]
37. Circulating CD8+ cytotoxic T lymphocytes specific for HTLV-I pX in patients with HTLV-I associated neurological disease.
Jacobson S; Shida H; McFarlin DE; Fauci AS; Koenig S
Nature; 1990 Nov; 348(6298):245-8. PubMed ID: 2146511
[TBL] [Abstract][Full Text] [Related]
38. Cross-neutralizing antibodies against cosmopolitan and Melanesian strains of human T cell leukemia/lymphotropic virus type I in sera from inhabitants of Africa and the Solomon Islands.
Benson J; Tschachler E; Gessain A; Yanagihara R; Gallo RC; Franchini G
AIDS Res Hum Retroviruses; 1994 Jan; 10(1):91-6. PubMed ID: 8179967
[TBL] [Abstract][Full Text] [Related]
39. Priming for in vitro and in vivo anti-human T lymphotropic virus type 1 cellular immunity by virus-related protein reconstituted into liposome.
Noguchi Y; Noguchi T; Sato T; Yokoo Y; Itoh S; Yoshida M; Yoshiki T; Akiyoshi K; Sunamoto J; Nakayama E
J Immunol; 1991 May; 146(10):3599-603. PubMed ID: 2026883
[TBL] [Abstract][Full Text] [Related]
40. HIV-specific T lymphocyte immunity in mice immunized with a recombinant vaccinia virus.
Michel F; Hoffenbach A; Langlade-Demoyen P; Guy B; Girard M; Lecocq JP; Wain-Hobson S; Kieny MP; Plata F
Eur J Immunol; 1988 Dec; 18(12):1917-24. PubMed ID: 2905993
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
